{
    "title": "FDA panel to debate US approval for Alzheimer's drug from Eisai and Biogen",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12177641/FDA-panel-debate-US-approval-Alzheimers-drug-Eisai-Biogen.html",
    "date": "2023-06-09",
    "keywords": [
        "approval",
        "drug",
        "treatment",
        "brain",
        "agency",
        "panel",
        "trial",
        "eisai",
        "payment",
        "leqembi",
        "latestage",
        "benefit",
        "access",
        "medicare",
        "registry",
        "plan",
        "amyloid",
        "june",
        "friday",
        "move",
        "food",
        "administration",
        "ability",
        "toxic",
        "decision",
        "july",
        "staff",
        "wednesday",
        "decline",
        "safety",
        "street",
        "sign",
        "analyst",
        "colin",
        "bristow",
        "meeting",
        "formality",
        "medicine",
        "class",
        "milestone",
        "health",
        "database",
        "advocacy",
        "opposition",
        "coverage",
        "participation",
        "expert",
        "mindrobbing",
        "disease",
        "focus",
        "gene",
        "fda",
        "input",
        "blood",
        "condition",
        "angiopathy",
        "protein",
        "artery",
        "bleeding",
        "issue",
        "vote",
        "agencys",
        "contrast",
        "rejection",
        "aduhelm",
        "recommendation",
        "encore",
        "drama",
        "wedbush",
        "research",
        "note",
        "reporting",
        "leo",
        "bengaluru",
        "julie",
        "steenhuysen",
        "chicago",
        "editing",
        "humer",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}